These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

507 related items for PubMed ID: 21568008

  • 21. Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
    Lautenbach E, Strom BL, Bilker WB, Patel JB, Edelstein PH, Fishman NO.
    Clin Infect Dis; 2001 Oct 15; 33(8):1288-94. PubMed ID: 11565067
    [Abstract] [Full Text] [Related]

  • 22. [Epidemiological study on extended-spectrum beta-lactamase-producing in clinical isolates and selection of antibacterial drugs in China ].
    Yu YS.
    Zhonghua Yi Xue Za Zhi; 2004 Nov 17; 84(22):1918-20. PubMed ID: 15631810
    [No Abstract] [Full Text] [Related]

  • 23. Phenotypic confirmation of extended-spectrum B-lactamases (ESBL) in clinical isolates of Escherichia coli and Klebsiella pneumoniae at the San Juan Veterans Affairs Medical Center.
    Del Carmen Rodríguez M, Vera DE, Ramírez-Ronda CH, Saavedra S.
    P R Health Sci J; 2004 Sep 17; 23(3):207-15. PubMed ID: 15631176
    [Abstract] [Full Text] [Related]

  • 24. Use of cefepime for the treatment of infections caused by extended spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
    Labombardi VJ, Rojtman A, Tran K.
    Diagn Microbiol Infect Dis; 2006 Nov 17; 56(3):313-5. PubMed ID: 17084784
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Carbapenem therapy for bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.
    Lee NY, Huang WH, Tsui KC, Hsueh PR, Ko WC.
    Diagn Microbiol Infect Dis; 2011 May 17; 70(1):150-3. PubMed ID: 21398070
    [Abstract] [Full Text] [Related]

  • 27. Risk factors for infection and treatment outcome of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy.
    Kang CI, Chung DR, Ko KS, Peck KR, Song JH, Korean Network for Study of Infectious Diseases.
    Ann Hematol; 2012 Jan 17; 91(1):115-21. PubMed ID: 21556875
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Extended-spectrum beta-lactamase (ESBL) CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae in Sofia, Bulgaria.
    Markovska R, Schneider I, Keuleyan E, Bauernfeind A.
    Clin Microbiol Infect; 2004 Aug 17; 10(8):752-5. PubMed ID: 15301679
    [Abstract] [Full Text] [Related]

  • 30. An outbreak of hospital-acquired Klebsiella pneumoniae bacteraemia, including strains producing extended-spectrum beta-lactamase.
    Peña C, Pujol M, Ardanuy C, Ricart A, Pallarés R, Liñares J, Ariza J, Gudiol F.
    J Hosp Infect; 2001 Jan 17; 47(1):53-9. PubMed ID: 11161899
    [Abstract] [Full Text] [Related]

  • 31. Prevalence of extended spectrum beta-lactamase producing Escherichia coli and Klebsiella isolates in a large community teaching hospital in Connecticut.
    Dandekar PK, Tetreault J, Quinn JP, Nightingale CH, Nicolau DP.
    Diagn Microbiol Infect Dis; 2004 May 17; 49(1):37-9. PubMed ID: 15135498
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Emergence of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae during the years 2000 and 2004 in Helsinki, Finland.
    Forssten SD, Kolho E, Lauhio A, Lehtola L, Mero S, Oksaharju A, Jalava J, Tarkka E, Vaara M, Vuopio-Varkila J.
    Clin Microbiol Infect; 2010 Aug 17; 16(8):1158-61. PubMed ID: 20670290
    [Abstract] [Full Text] [Related]

  • 37. Ongoing epidemic of blaVIM-1-positive Klebsiella pneumoniae in Athens, Greece: a prospective survey.
    Psichogiou M, Tassios PT, Avlamis A, Stefanou I, Kosmidis C, Platsouka E, Paniara O, Xanthaki A, Toutouza M, Daikos GL, Tzouvelekis LS.
    J Antimicrob Chemother; 2008 Jan 17; 61(1):59-63. PubMed ID: 17999975
    [Abstract] [Full Text] [Related]

  • 38. Dissemination of SHV-12 and CTX-M-type extended-spectrum beta-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae and emergence of GES-3 in Korea.
    Ryoo NH, Kim EC, Hong SG, Park YJ, Lee K, Bae IK, Song EH, Jeong SH.
    J Antimicrob Chemother; 2005 Oct 17; 56(4):698-702. PubMed ID: 16141280
    [Abstract] [Full Text] [Related]

  • 39. Impact of Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae on the outcome of community-onset bacteremic urinary tract infections.
    Yang YS, Ku CH, Lin JC, Shang ST, Chiu CH, Yeh KM, Lin CC, Chang FY.
    J Microbiol Immunol Infect; 2010 Jun 17; 43(3):194-9. PubMed ID: 21291846
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.